All In Biotech

Free tool

FAERS Monitor: Augmentin Es-600

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050755 or its brand name (Augmentin Es-600, Amoxicillin, Clavulanate Potassium). Reports on generic versions are filed under their own applications.

Reports

4,551

Serious

3,751

82% of reports

Hospitalization

2,023

Death reported

433

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea384
  • dyspnoea357
  • pyrexia265
  • drug ineffective253
  • nausea244
  • fatigue239
  • pruritus230
  • vomiting229
  • pneumonia227
  • rash226
  • pain215
  • headache197
  • cough190
  • asthma179
  • condition aggravated178

Reports by year received

View as table
YearReports
2004206
2005149
200655
200755
200872
2009307
2010376
2011452
2012393
20139
201459
2015143
2016206
2017207
2018327
2019262
2020237
2021167
2022173
2023170
2024206
2025196
2026123

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,608 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
asthmaSignal1797.36.3976
pyrexiaSignal2653.53.2488
pneumoniaSignal2273.22.9355
coughSignal1903.12.7277
dyspnoeaSignal3572.92.6460
pruritusSignal2302.82.4262
diarrhoeaSignal3842.82.5439
condition aggravatedSignal1782.72.3193
rashSignal2262.42.1186
vomitingSignal2292.32.0162
pain2151.61.452
headache1971.51.328
nausea2441.41.332
fatigue2391.41.330
drug ineffective2530.90.84

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.